Literature DB >> 10993896

The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor.

J A Carson1, R A Fillmore, R J Schwartz, W E Zimmer.   

Abstract

An evolutionarily conserved vertebrate homologue of the Drosophila NK-3 homeodomain gene bagpipe, Nkx3-1, is expressed in vascular and visceral mesoderm-derived muscle tissues and may influence smooth muscle cell differentiation. Nkx3-1 was evaluated for mediating smooth muscle gamma-actin (SMGA) gene activity, a specific marker of smooth muscle differentiation. Expression of mNkx3-1 in heterologous CV-1 fibroblasts was unable to elicit SMGA promoter activity but required the coexpression of serum response factor (SRF) to activate robust SMGA transcription. A novel complex element containing a juxtaposed Nkx-binding site (NKE) and an SRF-binding element (SRE) in the proximal promoter region was found to be necessary for the Nkx3-1/SRF coactivation of SMGA transcription. Furthermore, Nkx3-1 and SRF associate through protein-protein interactions and the homeodomain region of Nkx3-1 facilitated SRF binding to the complex NKE.SRE. Mutagenesis of Nkx3-1 revealed an inhibitory domain within its C-terminal segment. In addition, mNkx3-1/SRF cooperative activity required an intact Nkx3-1 homeodomain along with the MADS box of SRF, which contains DNA binding and dimerization structural domains, and the contiguous C-terminal SRF activation domain. Thus, SMGA is a novel target for Nkx3-1, and the activity of Nkx3-1 on the SMGA promoter is dependent upon SRF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993896     DOI: 10.1074/jbc.M006532200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Decoding human regulatory circuits.

Authors:  William Thompson; Michael J Palumbo; Wyeth W Wasserman; Jun S Liu; Charles E Lawrence
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

Review 2.  Intracellular trafficking of nucleic acids.

Authors:  Rui Zhou; R Christopher Geiger; David A Dean
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

3.  Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.

Authors:  Steven O Simmons; Jonathan M Horowitz
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 4.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

Review 5.  Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.

Authors:  Erin E Vaughan; James V DeGiulio; David A Dean
Journal:  Curr Gene Ther       Date:  2006-12       Impact factor: 4.391

6.  Gene expression profiles in the PC-3 human prostate cancer cells induced by NKX3.1.

Authors:  Pengju Zhang; Wenwen Liu; Ju Zhang; Hengyun Guan; Weiwen Chen; Xing Cui; Qingwei Liu; Anli Jiang
Journal:  Mol Biol Rep       Date:  2009-05-22       Impact factor: 2.316

7.  Tbx18 regulates development of the epicardium and coronary vessels.

Authors:  San-Pin Wu; Xiu-Rong Dong; Jenna N Regan; Chang Su; Mark W Majesky
Journal:  Dev Biol       Date:  2013-09-07       Impact factor: 3.582

8.  Smooth muscle calponin: an unconventional CArG-dependent gene that antagonizes neointimal formation.

Authors:  Xiaochun Long; Orazio J Slivano; Sarah L Cowan; Mary A Georger; Ting-Hein Lee; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

Review 9.  Signaling mechanisms that regulate smooth muscle cell differentiation.

Authors:  Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

10.  Prediction of cell type-specific gene modules: identification and initial characterization of a core set of smooth muscle-specific genes.

Authors:  Sven Nelander; Petter Mostad; Per Lindahl
Journal:  Genome Res       Date:  2003-07-17       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.